Corpus Intelligence IC Memo — BEAUMONT HOSPITAL - DEARBORN 2026-04-26 04:04 UTC
IC Memo — BEAUMONT HOSPITAL - DEARBORN
Investment Committee Memorandum | MI | 567 beds | Grade C | EBITDA uplift $49.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BEAUMONT HOSPITAL - DEARBORN

CCN 230020 | nan, MI | 567 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BEAUMONT HOSPITAL - DEARBORN is a 567-bed suburban community hospital in nan, MI with $671.1M in net patient revenue and a -5.5% operating margin. The hospital serves a payer mix of 22.7% Medicare, 4.3% Medicaid, and 73.0% commercial.

Thesis: Undervalued. Our ML models identify $49.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.5% to 1.9% (+736bps).

Net Revenue HCRIS$671.1M
Current EBITDA COMPUTED$-36.9M
Operating Margin COMPUTED-5.5%
Occupancy HCRIS69.4%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS20.8%
Distress Probability ML44.1%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
19
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -5.5% places it below the state median. Among 19 size-comparable peers (284-1134 beds), the median margin is -7.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (284-1134), prioritizing same-state peers. 19 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BEAUMONT HOSPITAL - DEARBORN (Target)MI567$671.1M-5.5%
UNIV OF MI HOSPITALS & HLTH CTMI951$4.62B-1.4%
SPECTRUM HEALTH HOSPITALSMI1103$2.57B0.0%
HENRY FORD HOSPITALMI670$2.32B-14.8%
WILLIAM BEAUMONT HOSPITAL- ROYMI1026$1.56B-0.8%
BRONSON METHODIST HOSPITALMI439$1.06B-1.4%
TRINITY HEALTH ANN ARBORMI475$1.00B-1.0%
EDWARD W. SPARROW HOSPITALMI425$936.1M-24.5%
ASCENSION ST JOHN HOSPITALMI556$929.1M-9.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $49.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$14.1M+210bp18mo
Cost to Collect4.5%2.5%$13.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$13.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$8.2M+122bp9mo
Clean Claim Rate88.0%96.0%$429K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$14.1M
Cost to Collect
$13.4M
Denial Rate Reduction
$13.3M
A/R Days Reduction
$8.2M
Clean Claim Rate
$429K
Total EBITDA Uplift$49.4M
Current EBITDA$-36.9M
+ RCM Uplift+$49.4M
Pro Forma EBITDA$12.5M
Current Margin-5.5%
Pro Forma Margin1.9%
WC Released (1x)$25.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-56.8M$250.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-56.8M$257.2M0.00x-100.0%
Bull Case9.0x11.0x$-51.1M$401.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-51.1M$423.2M0.00x-100.0%
Bear Case11.0x10.0x$-62.4M$22.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-62.4M$4.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 19 hospitals with 284-1134 beds
  • Same-state prioritization (n=20)
  • Comp margins: P25=-9.9% / P50=-7.0% / P75=-1.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.